157 related articles for article (PubMed ID: 17077607)
21. Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells.
Murakami S; Sakurai F; Kawabata K; Okada N; Fujita T; Yamamoto A; Hayakawa T; Mizuguchi H
Gene Ther; 2007 Nov; 14(21):1525-33. PubMed ID: 17805302
[TBL] [Abstract][Full Text] [Related]
22. A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy.
Yang M; Yang CS; Guo W; Tang J; Huang Q; Feng S; Jiang A; Xu X; Jiang G; Liu YQ
Cancer Biol Ther; 2017 Nov; 18(11):833-840. PubMed ID: 29144842
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers.
Cho YS; Do MH; Kwon SY; Moon C; Kim K; Lee K; Lee SJ; Hemmi S; Joo YE; Kim MS; Jung C
Oncotarget; 2016 Jun; 7(25):38210-38223. PubMed ID: 27203670
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes.
Mizuguchi H; Hayakawa T
Gene; 2002 Feb; 285(1-2):69-77. PubMed ID: 12039033
[TBL] [Abstract][Full Text] [Related]
25. Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo.
Denby L; Work LM; Graham D; Hsu C; von Seggern DJ; Nicklin SA; Baker AH
Hum Gene Ther; 2004 Nov; 15(11):1054-64. PubMed ID: 15610606
[TBL] [Abstract][Full Text] [Related]
26. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.
Nanda A; Lynch DM; Goudsmit J; Lemckert AA; Ewald BA; Sumida SM; Truitt DM; Abbink P; Kishko MG; Gorgone DA; Lifton MA; Shen L; Carville A; Mansfield KG; Havenga MJ; Barouch DH
J Virol; 2005 Nov; 79(22):14161-8. PubMed ID: 16254351
[TBL] [Abstract][Full Text] [Related]
28. CD46 represents a target for adenoviral gene therapy of malignant glioma.
Ulasov IV; Tyler MA; Zheng S; Han Y; Lesniak MS
Hum Gene Ther; 2006 May; 17(5):556-64. PubMed ID: 16716112
[TBL] [Abstract][Full Text] [Related]
29. Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.
Lewis TB; Glasgow JN; Glandon AM; Curiel DT; Standaert DG
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862245
[TBL] [Abstract][Full Text] [Related]
30. The short consensus repeats 1 and 2, not the cytoplasmic domain, of human CD46 are crucial for infection of subgroup B adenovirus serotype 35.
Sakurai F; Murakami S; Kawabata K; Okada N; Yamamoto A; Seya T; Hayakawa T; Mizuguchi H
J Control Release; 2006 Jul; 113(3):271-8. PubMed ID: 16790289
[TBL] [Abstract][Full Text] [Related]
31. Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob.
Matsui H; Sakurai F; Katayama K; Kurachi S; Tashiro K; Sugio K; Kawabata K; Mizuguchi H
Virus Res; 2011 Jan; 155(1):48-54. PubMed ID: 20801174
[TBL] [Abstract][Full Text] [Related]
32. Development and assessment of human adenovirus type 11 as a gene transfer vector.
Stone D; Ni S; Li ZY; Gaggar A; DiPaolo N; Feng Q; Sandig V; Lieber A
J Virol; 2005 Apr; 79(8):5090-104. PubMed ID: 15795294
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination.
DiPaolo N; Ni S; Gaggar A; Strauss R; Tuve S; Li ZY; Stone D; Shayakhmetov D; Kiviat N; Touré P; Sow S; Horvat B; Lieber A
Mol Ther; 2006 Apr; 13(4):756-65. PubMed ID: 16461009
[TBL] [Abstract][Full Text] [Related]
34. CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy.
Camacho ZT; Turner MA; Barry MA; Weaver EA
Hum Gene Ther; 2014 Apr; 25(4):364-74. PubMed ID: 24635714
[TBL] [Abstract][Full Text] [Related]
35. Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer.
Do MH; To PK; Cho YS; Kwon SY; Hwang EC; Choi C; Cho SH; Lee SJ; Hemmi S; Jung C
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201920
[TBL] [Abstract][Full Text] [Related]
36. Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells.
Yu L; Takenobu H; Shimozato O; Kawamura K; Nimura Y; Seki N; Uzawa K; Tanzawa H; Shimada H; Ochiai T; Tagawa M
Oncol Rep; 2005 Oct; 14(4):831-5. PubMed ID: 16142339
[TBL] [Abstract][Full Text] [Related]
37. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.
Mack CA; Song WR; Carpenter H; Wickham TJ; Kovesdi I; Harvey BG; Magovern CJ; Isom OW; Rosengart T; Falck-Pedersen E; Hackett NR; Crystal RG; Mastrangeli A
Hum Gene Ther; 1997 Jan; 8(1):99-109. PubMed ID: 8989999
[TBL] [Abstract][Full Text] [Related]
38. Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.
Hamilton MM; Byrnes GA; Gall JG; Brough DE; King CR; Wei LL
Mol Vis; 2008; 14():2535-46. PubMed ID: 19122827
[TBL] [Abstract][Full Text] [Related]
39. Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob.
Wang H; Liaw YC; Stone D; Kalyuzhniy O; Amiraslanov I; Tuve S; Verlinde CL; Shayakhmetov D; Stehle T; Roffler S; Lieber A
J Virol; 2007 Dec; 81(23):12785-92. PubMed ID: 17898059
[TBL] [Abstract][Full Text] [Related]
40. Development of fiber-substituted adenovirus vectors containing foreign peptides in the adenovirus serotype 35 fiber knob.
Matsui H; Sakurai F; Kurachi S; Tashiro K; Sugio K; Kawabata K; Yamanishi K; Mizuguchi H
Gene Ther; 2009 Aug; 16(8):1050-7. PubMed ID: 19516278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
